Analytical Data
-
Gene name
KXD1
- Application
-
Alternative Names
KXD1;C19orf50;KxDL motif-containing Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BQD3
-
Expression Region
1-179aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMDLPDSA SRVFCGRILS MVNTDDVNAI ILAQKNMLDR FEKTNEMLLN FNNLSSARLQ QMSERFLHHT RTLVEMKRDL DSIFRRIRTL KGKLARQHPE AFSHIPEASF LEEEDEDPIP PSTTTTIATS EQSTGSCDTS PDTVSPSLSP GFEDLSHVQP GSPAINGRSQ TDDEEMTGE
-
Molecular Weight
22 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KXD1 recombinant protein has emerged as an important focus in the field of molecular biology due to its potential implications in various cellular processes and diseases. Identified as a member of a unique protein family, KXD1 is believed to play a critical role in intracellular signaling, endoplasmic reticulum function, and cellular stress responses. Its involvement in these processes has attracted significant attention, particularly in the context of cancer and neurological disorders, where dysregulation of similar proteins has been implicated in disease progression. Recent studies highlight the necessity of understanding KXD1's structure and function to elucidate its biological significance. Recombinant technology allows for the production of KXD1 in a controlled environment, facilitating detailed studies on its properties, interactions, and functional roles. By generating KXD1 protein in sufficient quantities, researchers can conduct experiments such as structural analysis, binding assays, and functional assays, which are essential for deciphering the molecular mechanisms underlying its action. Additionally, probing the effects of KXD1 in various cellular models can provide insights into its potential as a therapeutic target. As the research progresses, understanding the role of KXD1 may pave the way for novel strategies in treating diseases associated with its dysregulation, making it a pivotal subject of study in contemporary biomedical research.
